Evaluating Retention Rates in a Medication-Assisted Treatment Program

被引:3
|
作者
Rioux, Jennifer [1 ]
Cuellar, Norma [1 ]
Oliver, JoAnn [1 ]
Hsu, Powen [2 ]
Szapkiw, Amanda
机构
[1] Univ Alabama, Capstone Coll Nursing, Tuscaloosa, AL 35401 USA
[2] Tufts Univ, New Era Med, Boston, MA 02111 USA
来源
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2020年 / 16卷 / 09期
关键词
medication-assisted treatment; opioid agonist therapy; opioid replacement therapy; opioid use disorder;
D O I
10.1016/j.nurpra.2020.06.028
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Only a few medications are available for the treatment of opioid use disorder (OUD), and few data exist regarding which medication is more likely to increase retention in a substance use treatment program. Findings from a retrospective review of an opioid use treatment program revealed an increase in retention rates for those receiving injectable buprenorphine extended-release (Sublocade) over those receiving transmucosal buprenorphine tablets/films (Suboxone). Because fatal opioid overdoses now lead the United States in injury-related deaths, it is imperative to provide data to health care providers that can help guide effective prescribing to save lives. (c) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:E149 / E151
页数:3
相关论文
共 50 条
  • [1] Retention in medication-assisted treatment for opiate dependence: A systematic review
    Timko, Christine
    Schultz, Nicole R.
    Cucciare, Michael A.
    Vittorio, Lisa
    Garrison-Diehn, Christina
    JOURNAL OF ADDICTIVE DISEASES, 2016, 35 (01) : 22 - 35
  • [2] Trends in Abstinence and Retention Associated with a Medication-Assisted Treatment Program for People with Opioid Use Disorders
    Brunisholz, Kimberly D.
    Knighton, Andrew J.
    Sharma, Amulya
    Nichols, Lisa
    Reisig, Kristen
    Burton, Jed
    Scovill, Debbie
    Tometich, Carolyn
    Foote, Mark
    Read, Shelly
    Whittle, Scott
    PROGRESS IN COMMUNITY HEALTH PARTNERSHIPS-RESEARCH EDUCATION AND ACTION, 2020, 14 (01) : 43 - 54
  • [3] Successful Medication-Assisted Treatment Program at a Community Emergency Department
    Reuter, Q.
    Smith, G.
    McKinnon, J.
    Varley, J.
    Jouriles, N.
    Seaberg, D.
    ANNALS OF EMERGENCY MEDICINE, 2019, 74 (04) : S89 - S89
  • [4] Use of Psychological Surveys to Predict Retention in Medication-Assisted Treatment Programs
    Seaberg, D.
    Vellanki, S.
    Moran, M.
    Patrick, P.
    McKinnon, J.
    Haelston, L.
    Jouriles, N.
    ANNALS OF EMERGENCY MEDICINE, 2023, 82 (04) : S36 - S37
  • [5] Predictors of Family Medicine Patient Retention in Opioid Medication-Assisted Treatment
    Justesen, Kathryn
    Hooker, Stephanie A.
    Sherman, Michelle D.
    Lonergan-Cullum, Mary
    Nissly, Tanner
    Levy, Robert
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2020, 33 (06) : 848 - 857
  • [6] Reconsidering medication-assisted drug treatment
    Stenius, Kerstin
    NORDIC STUDIES ON ALCOHOL AND DRUGS, 2012, 29 (02) : 123 - 124
  • [7] Medication-Assisted Treatment in the Perianesthesia Setting
    Broglio, Kathleen
    Cooney, Maureen F.
    JOURNAL OF PERIANESTHESIA NURSING, 2017, 32 (03) : 260 - 263
  • [8] Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program
    Kaucher, Kevin A.
    Caruso, Emily H.
    Sungar, Gannon
    Gawenus, Lisa
    Hurlbut, Katherine
    Sanchez, Dayan Colon
    Broderick, Kerry
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 38 (02): : 300 - 304
  • [9] Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence
    Thomas, Cindy Parks
    Fullerton, Catherine Anne
    Kim, Meelee
    Montejano, Leslie
    Lyman, D. Russell
    Dougherty, Richard H.
    Daniels, Allen S.
    Ghose, Sushmita Shoma
    Delphin-Rittmon, Miriam E.
    PSYCHIATRIC SERVICES, 2014, 65 (02) : 158 - 170
  • [10] MEDICATION-ASSISTED TREATMENT OF DRUG-ADDICTS
    BSCHOR, F
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (43) : 1658 - 1659